secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-10-01T23:59:59+00:00
Accession:  0001193125-24-230319
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 2.01, 2.02, 2.03, 3.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix launches £10M placing, restructures debt, plans Nasdaq delisting
--------------------------------------------------------------------------

- Minimum £10M gross raised at 9p/share; first tranche of £2.1M closes Oct 9, second tranche conditional on shareholder vote.
- FY24 preliminary IFRS revenue $2.3M, loss before tax $44.9M (incl. $10.2M impairment), cash $4.7M, net liabilities -$8.5M.
- Convertible bond restructured: £2.75M of $11.66M principal converted to shares; balance to new 5.5%/7.5% note due 2029.
- Voluntary delisting from Nasdaq effective ~Oct 7; ADSs to trade on OTCQX Marketplace.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000119312524230319/0001193125-24-230319-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000119312524230319/d896405d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-230319

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer